ARS Pharmaceuticals Inc

NASDAQ:SPRY   4:00:00 PM EDT
7.47
-0.18 (-2.35%)
7:59:51 PM EDT: $7.65 +0.18 (+2.41%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)700.48M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.08 Million
Adjusted EPS-$0.22
See more estimates
10-Day MA$7.16
50-Day MA$7.34
200-Day MA$5.40
See more pivots

ARS Pharmaceuticals Inc Stock, NASDAQ:SPRY

11682 El Camino Real, Suite 120, San Diego, California 92130
United States of America
Phone: +1.858.771.9307
Number of Employees: 90

Description

ARS Pharmaceuticals, Inc. engages in developing neffyâ„¢, an intranasal epinephrine product in clinical development for patients and their caregivers with Type I allergic reactions including food, medications, and insect bites that could lead to life-threatening anaphylaxis. The company is headquartered in San Diego, CA.